Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study

Constitutional heterozygous pathogenic variants in genes coding for some components of the Fanconi anemia-BRCA signaling pathway, which repairs DNA interstrand crosslinks, represent risk factors for common cancers, including breast, ovarian, pancreatic and prostate cancer. A high cancer risk is also...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kastellan, Svenja (VerfasserIn) , Kalb, Reinhard (VerfasserIn) , Sajjad, Bia (VerfasserIn) , McReynolds, Lisa J. (VerfasserIn) , Giri, Neelam (VerfasserIn) , Samuel, David (VerfasserIn) , Milde, Till (VerfasserIn) , Elbracht, Miriam (VerfasserIn) , Holzhauer, Susanne (VerfasserIn) , Niewisch, Marena R. (VerfasserIn) , Kratz, Christian P. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 29 April 2024
In: Journal of hematology & oncology
Year: 2024, Jahrgang: 17, Pages: 1-5
ISSN:1756-8722
DOI:10.1186/s13045-024-01547-4
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s13045-024-01547-4
Volltext
Verfasserangaben:Svenja Kastellan, Reinhard Kalb, Bia Sajjad, Lisa J. McReynolds, Neelam Giri, David Samuel, Till Milde, Miriam Elbracht, Susanne Holzhauer, Marena R. Niewisch and Christian P. Kratz

MARC

LEADER 00000caa a2200000 c 4500
001 1920623884
003 DE-627
005 20250717003122.0
007 cr uuu---uuuuu
008 250326s2024 xx |||||o 00| ||eng c
024 7 |a 10.1186/s13045-024-01547-4  |2 doi 
035 |a (DE-627)1920623884 
035 |a (DE-599)KXP1920623884 
035 |a (OCoLC)1528043751 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kastellan, Svenja  |e VerfasserIn  |0 (DE-588)1361389036  |0 (DE-627)1920625585  |4 aut 
245 1 0 |a Germline biallelic BRCA2 pathogenic variants and medulloblastoma  |b an international cohort study  |c Svenja Kastellan, Reinhard Kalb, Bia Sajjad, Lisa J. McReynolds, Neelam Giri, David Samuel, Till Milde, Miriam Elbracht, Susanne Holzhauer, Marena R. Niewisch and Christian P. Kratz 
264 1 |c 29 April 2024 
300 |a 5 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 26.03.2025 
520 |a Constitutional heterozygous pathogenic variants in genes coding for some components of the Fanconi anemia-BRCA signaling pathway, which repairs DNA interstrand crosslinks, represent risk factors for common cancers, including breast, ovarian, pancreatic and prostate cancer. A high cancer risk is also a main clinical feature in patients with Fanconi anemia (FA), a rare condition characterized by bone marrow failure, endocrine and physical abnormalities. The mainly recessive condition is caused by germline pathogenic variants in one of 21 FA-BRCA pathway genes. Among patients with FA, the highest cancer risks are observed in patients with biallelic pathogenic variants in BRCA2 or PALB2. These patients develop a range of embryonal tumors and leukemia during the first decade of life, however, little is known about specific clinical, genetic and pathologic features or toxicities. Here, we present genetic, clinical, pathological and treatment characteristics observed in an international cohort of eight patients with FA due to biallelic BRCA2 pathogenic variants and medulloblastoma (MB), an embryonal tumor of the cerebellum. Median age at MB diagnosis was 32.5 months (range 7-58 months). All patients with available data had sonic hedgehog-MB. Six patients received chemotherapy and one patient also received proton radiation treatment. No life-threatening toxicities were documented. Prognosis was poor and all patients died shortly after MB diagnosis (median survival time 4.5 months, range 0-21 months) due to MB or other neoplasms. In conclusion, MB in patients with biallelic BRCA2 pathogenic variants is a lethal disease. Future experimental treatments are necessary to help these patients. 
650 4 |a Alleles 
650 4 |a BRCA2 
650 4 |a BRCA2 Protein 
650 4 |a Cerebellar Neoplasms 
650 4 |a Child, Preschool 
650 4 |a Cohort Studies 
650 4 |a Fanconi anemia 
650 4 |a Fanconi Anemia 
650 4 |a Female 
650 4 |a Germ-Line Mutation 
650 4 |a Humans 
650 4 |a Infant 
650 4 |a Male 
650 4 |a Medulloblastoma 
700 1 |a Kalb, Reinhard  |e VerfasserIn  |4 aut 
700 1 |a Sajjad, Bia  |e VerfasserIn  |4 aut 
700 1 |a McReynolds, Lisa J.  |e VerfasserIn  |4 aut 
700 1 |a Giri, Neelam  |e VerfasserIn  |4 aut 
700 1 |a Samuel, David  |e VerfasserIn  |4 aut 
700 1 |a Milde, Till  |d 1973-  |e VerfasserIn  |0 (DE-588)1038311837  |0 (DE-627)75711234X  |0 (DE-576)39229334X  |4 aut 
700 1 |a Elbracht, Miriam  |e VerfasserIn  |4 aut 
700 1 |a Holzhauer, Susanne  |e VerfasserIn  |4 aut 
700 1 |a Niewisch, Marena R.  |e VerfasserIn  |4 aut 
700 1 |a Kratz, Christian P.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Journal of hematology & oncology  |d London : Biomed Central, 2008  |g 17(2024), Artikel-ID 26, Seite 1-5  |h Online-Ressource  |w (DE-627)568914813  |w (DE-600)2429631-4  |w (DE-576)281703132  |x 1756-8722  |7 nnas  |a Germline biallelic BRCA2 pathogenic variants and medulloblastoma an international cohort study 
773 1 8 |g volume:17  |g year:2024  |g elocationid:26  |g pages:1-5  |g extent:5  |a Germline biallelic BRCA2 pathogenic variants and medulloblastoma an international cohort study 
856 4 0 |u https://doi.org/10.1186/s13045-024-01547-4  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20250326 
993 |a Article 
994 |a 2024 
998 |g 1038311837  |a Milde, Till  |m 1038311837:Milde, Till  |d 50000  |e 50000PM1038311837  |k 0/50000/  |p 7 
999 |a KXP-PPN1920623884  |e 4693587559 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"titleAlt":[{"title":"Journal of hematology and oncology"}],"pubHistory":["1.2008 -"],"note":["Gesehen am 19.06.2020"],"language":["eng"],"disp":"Germline biallelic BRCA2 pathogenic variants and medulloblastoma an international cohort studyJournal of hematology & oncology","origin":[{"publisher":"Biomed Central","publisherPlace":"London","dateIssuedKey":"2008","dateIssuedDisp":"2008-"}],"id":{"eki":["568914813"],"zdb":["2429631-4"],"issn":["1756-8722"]},"recId":"568914813","type":{"media":"Online-Ressource","bibl":"periodical"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Journal of hematology & oncology","title_sort":"Journal of hematology & oncology"}],"part":{"extent":"5","pages":"1-5","text":"17(2024), Artikel-ID 26, Seite 1-5","year":"2024","volume":"17"}}],"title":[{"subtitle":"an international cohort study","title_sort":"Germline biallelic BRCA2 pathogenic variants and medulloblastoma","title":"Germline biallelic BRCA2 pathogenic variants and medulloblastoma"}],"physDesc":[{"extent":"5 S."}],"language":["eng"],"note":["Gesehen am 26.03.2025"],"person":[{"given":"Svenja","display":"Kastellan, Svenja","family":"Kastellan","role":"aut"},{"family":"Kalb","role":"aut","display":"Kalb, Reinhard","given":"Reinhard"},{"given":"Bia","role":"aut","family":"Sajjad","display":"Sajjad, Bia"},{"display":"McReynolds, Lisa J.","role":"aut","family":"McReynolds","given":"Lisa J."},{"given":"Neelam","role":"aut","family":"Giri","display":"Giri, Neelam"},{"given":"David","family":"Samuel","role":"aut","display":"Samuel, David"},{"given":"Till","display":"Milde, Till","family":"Milde","role":"aut"},{"display":"Elbracht, Miriam","family":"Elbracht","role":"aut","given":"Miriam"},{"role":"aut","family":"Holzhauer","display":"Holzhauer, Susanne","given":"Susanne"},{"display":"Niewisch, Marena R.","family":"Niewisch","role":"aut","given":"Marena R."},{"display":"Kratz, Christian P.","family":"Kratz","role":"aut","given":"Christian P."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"eki":["1920623884"],"doi":["10.1186/s13045-024-01547-4"]},"recId":"1920623884","origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"29 April 2024"}],"name":{"displayForm":["Svenja Kastellan, Reinhard Kalb, Bia Sajjad, Lisa J. McReynolds, Neelam Giri, David Samuel, Till Milde, Miriam Elbracht, Susanne Holzhauer, Marena R. Niewisch and Christian P. Kratz"]}} 
SRT |a KASTELLANSGERMLINEBI2920